Cardiac Biomarkers Market Is Predicted To Grow Quickly Due To The High Worldwide Prevalence Of ACS Acts Till 2024: Grand View Research, Inc.
The cardiac biomarkers market is expected to reach USD13.3 billion by
2024, according to a new report by Grand View Research, Inc. The cardiac
biomarkers market is anticipated to witness a lucrative growth during the
forecast period from 2016 to 2024. Analysis of global market trends focuses on
the increasing demand for cardiac biomarkers owing to its increased adoption in
cardiovascular disease diagnosis. Furthermore, this growth is attributed to a
majority of factors, such as the high prevalence of Acute Coronary Syndrome
(ACS), continual technological advancements in the development of
cardiovascular biomarkers, increasing number of new product launches by the key
market players, rising demand for point of care cardiac testing kits, along
with the high specificity and sensitivity of these biomarkers in the detection
of cardiovascular diseases, especially acute myocardial infarction.
The cardiac biomarkers market has
been classified by type into troponin, Creatine kinase-MB(CK-MB), B-type
Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide
(NT-proBNP), myoglobin, and others. Troponin is a heteromeric protein and
comprises cardiac troponin T & I, which are abbreviated as cTnT & cTnI,
respectively. The troponin biomarkers segment is expected to grow lucratively
in the forecast period at a significant CAGR. The diagnostic efficiency and
specificity related to cardiac biomarker testing renders it a universally gold
standard test to diagnose cardiovascular disorders worldwide. The market by
application is segmented into acute coronary syndrome, myocardial infarction,
congestive heart failure, and others. ACS is expected to be the highest
grossing segment according to the study. ACS is responsible for huge medical
costs globally and is responsible for most hospital readmission cases. The
increasing efforts to cut down worldwide ACS prevalence rates are expected to
drive the growth of the biomarkers market.
The key countries included in the
report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South
Africa, and the Middle East. North America accounted for the largest market in
2015, whereas the Asia Pacific region is anticipated to be the fastest growing
region during the forecast period.
Browse full research report on Cardiac Biomarkers Market: http://www.grandviewresearch.com/industry-analysis/cardiac-biomarker-market
Further key findings from
the study suggest:
- North America is estimated to dominate the global
cardiac biomarkers market. The high prevalence of coronary heart disease
in western countries is one of the major factors contributing to the high
demand for cardiac biomarker diagnostics.
- The Asia Pacific region is anticipated to be the
fastest growing region in the study period owing to the large population,
especially in China and India. Apart from that, there exists a high
prevalence rate of myocardial infarction in the region. This prevalence
rate is expected to fuel the demand for cardiac biomarker diagnostics.
- The troponin biomarker segment is expected to grow at
a significant rate, and is expected to grow at the highest CAGR compared
to others and accounts for the largest market share in 2015.
- The sector comprises of several local as well as
global players. Some of the major players of this vertical include Alere,
Inc., Siemens Healthcare GmbH, Roche Diagnostics, Beckman Coulter, Inc.,
Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and bioMerieux
SA.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the cardiac biomarkers
market on the basis of type, application, end use, and region:
Cardiac Biomarkers Type Outlook (Revenue, USD
Million, 2013 - 2024)
- Troponin
- CK-MB
- Natriuretic
peptides - BNP and NT-proBNP
- Myoglobin
- Others
Cardiac Biomarkers Market Application Outlook (Revenue,
USD Million, 2013 - 2024)
- Acute
Coronary Syndrome
- Myocardial
infarction
- Congestive
heart failure
- Others
Cardiac Biomarkers Market End-use Outlook (Revenue, USD
Million, 2013 - 2024)
- Laboratory
Testing
- Point
of Care Testing
Cardiac Biomarkers Regional Outlook (Revenue, USD
Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
- Middle
East
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiac-biomarker-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment